Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15324775 | Publishing Date : 21-Feb-2020 | No. of pages : 90
Detailed TOC of Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antinuclear Antibody (ANA) Test Revenue
1.4 Market Analysis by Type
1.4.1 Global Antinuclear Antibody (ANA) Test Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Reagents & Assay Kits
1.4.3 Systems
1.4.4 Software & Service
1.5 Market by Application
1.5.1 Global Antinuclear Antibody (ANA) Test Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinical Laboratories
1.5.4 Physician Office Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Antinuclear Antibody (ANA) Test Market Perspective (2015-2026)
2.2 Antinuclear Antibody (ANA) Test Growth Trends by Regions
2.2.1 Antinuclear Antibody (ANA) Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antinuclear Antibody (ANA) Test Historic Market Share by Regions (2015-2020)
2.2.3 Antinuclear Antibody (ANA) Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Antinuclear Antibody (ANA) Test Market Growth Strategy
2.3.6 Primary Interviews with Key Antinuclear Antibody (ANA) Test Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Antinuclear Antibody (ANA) Test Players by Market Size
3.1.1 Global Top Antinuclear Antibody (ANA) Test Players by Revenue (2015-2020)
3.1.2 Global Antinuclear Antibody (ANA) Test Revenue Market Share by Players (2015-2020)
3.1.3 Global Antinuclear Antibody (ANA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antinuclear Antibody (ANA) Test Market Concentration Ratio
3.2.1 Global Antinuclear Antibody (ANA) Test Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antinuclear Antibody (ANA) Test Revenue in 2019
3.3 Antinuclear Antibody (ANA) Test Key Players Head office and Area Served
3.4 Key Players Antinuclear Antibody (ANA) Test Product Solution and Service
3.5 Date of Enter into Antinuclear Antibody (ANA) Test Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Antinuclear Antibody (ANA) Test Historic Market Size by Type (2015-2020)
4.2 Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Type (2021-2026)
5 Antinuclear Antibody (ANA) Test Breakdown Data by Application (2015-2026)
5.1 Global Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
5.2 Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Antinuclear Antibody (ANA) Test Market Size (2015-2020)
6.2 Antinuclear Antibody (ANA) Test Key Players in North America (2019-2020)
6.3 North America Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
6.4 North America Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
7 Europe
7.1 Europe Antinuclear Antibody (ANA) Test Market Size (2015-2020)
7.2 Antinuclear Antibody (ANA) Test Key Players in Europe (2019-2020)
7.3 Europe Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
7.4 Europe Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
8 China
8.1 China Antinuclear Antibody (ANA) Test Market Size (2015-2020)
8.2 Antinuclear Antibody (ANA) Test Key Players in China (2019-2020)
8.3 China Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
8.4 China Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
9 Japan
9.1 Japan Antinuclear Antibody (ANA) Test Market Size (2015-2020)
9.2 Antinuclear Antibody (ANA) Test Key Players in Japan (2019-2020)
9.3 Japan Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
9.4 Japan Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Antinuclear Antibody (ANA) Test Market Size (2015-2020)
10.2 Antinuclear Antibody (ANA) Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
10.4 Southeast Asia Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
11 India
11.1 India Antinuclear Antibody (ANA) Test Market Size (2015-2020)
11.2 Antinuclear Antibody (ANA) Test Key Players in India (2019-2020)
11.3 India Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
11.4 India Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Antinuclear Antibody (ANA) Test Market Size (2015-2020)
12.2 Antinuclear Antibody (ANA) Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020)
12.4 Central & South America Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Antinuclear Antibody (ANA) Test Introduction
13.1.4 Abbott Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Bio-Rad Laboratories, Inc
13.2.1 Bio-Rad Laboratories, Inc Company Details
13.2.2 Bio-Rad Laboratories, Inc Business Overview and Its Total Revenue
13.2.3 Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Introduction
13.2.4 Bio-Rad Laboratories, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.2.5 Bio-Rad Laboratories, Inc Recent Development
13.3 ERBA Diagnostics, Inc
13.3.1 ERBA Diagnostics, Inc Company Details
13.3.2 ERBA Diagnostics, Inc Business Overview and Its Total Revenue
13.3.3 ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Introduction
13.3.4 ERBA Diagnostics, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.3.5 ERBA Diagnostics, Inc Recent Development
13.4 Trinity Biotech plc
13.4.1 Trinity Biotech plc Company Details
13.4.2 Trinity Biotech plc Business Overview and Its Total Revenue
13.4.3 Trinity Biotech plc Antinuclear Antibody (ANA) Test Introduction
13.4.4 Trinity Biotech plc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.4.5 Trinity Biotech plc Recent Development
13.5 Thermo Fisher Scientific, Inc
13.5.1 Thermo Fisher Scientific, Inc Company Details
13.5.2 Thermo Fisher Scientific, Inc Business Overview and Its Total Revenue
13.5.3 Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Introduction
13.5.4 Thermo Fisher Scientific, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.5.5 Thermo Fisher Scientific, Inc Recent Development
13.6 Antibodies, Inc
13.6.1 Antibodies, Inc Company Details
13.6.2 Antibodies, Inc Business Overview and Its Total Revenue
13.6.3 Antibodies, Inc Antinuclear Antibody (ANA) Test Introduction
13.6.4 Antibodies, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.6.5 Antibodies, Inc Recent Development
13.7 EUROIMMUN AG
13.7.1 EUROIMMUN AG Company Details
13.7.2 EUROIMMUN AG Business Overview and Its Total Revenue
13.7.3 EUROIMMUN AG Antinuclear Antibody (ANA) Test Introduction
13.7.4 EUROIMMUN AG Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.7.5 EUROIMMUN AG Recent Development
13.8 Immuno Concepts
13.8.1 Immuno Concepts Company Details
13.8.2 Immuno Concepts Business Overview and Its Total Revenue
13.8.3 Immuno Concepts Antinuclear Antibody (ANA) Test Introduction
13.8.4 Immuno Concepts Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.8.5 Immuno Concepts Recent Development
13.9 Inova Diagnostics
13.9.1 Inova Diagnostics Company Details
13.9.2 Inova Diagnostics Business Overview and Its Total Revenue
13.9.3 Inova Diagnostics Antinuclear Antibody (ANA) Test Introduction
13.9.4 Inova Diagnostics Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.9.5 Inova Diagnostics Recent Development
13.10 Zeus Scientific
13.10.1 Zeus Scientific Company Details
13.10.2 Zeus Scientific Business Overview and Its Total Revenue
13.10.3 Zeus Scientific Antinuclear Antibody (ANA) Test Introduction
13.10.4 Zeus Scientific Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020)
13.10.5 Zeus Scientific Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Antinuclear Antibody (ANA) Test Key Market Segments
Table 2. Key Players Covered: Ranking by Antinuclear Antibody (ANA) Test Revenue
Table 3. Ranking of Global Top Antinuclear Antibody (ANA) Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antinuclear Antibody (ANA) Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents & Assay Kits
Table 6. Key Players of Systems
Table 7. Key Players of Software & Service
Table 8. Global Antinuclear Antibody (ANA) Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Antinuclear Antibody (ANA) Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Antinuclear Antibody (ANA) Test Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2015-2020)
Table 12. Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Antinuclear Antibody (ANA) Test Market Growth Strategy
Table 18. Main Points Interviewed from Key Antinuclear Antibody (ANA) Test Players
Table 19. Global Antinuclear Antibody (ANA) Test Revenue by Players (2015-2020) (Million US$)
Table 20. Global Antinuclear Antibody (ANA) Test Market Share by Players (2015-2020)
Table 21. Global Top Antinuclear Antibody (ANA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody (ANA) Test as of 2019)
Table 22. Global Antinuclear Antibody (ANA) Test by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antinuclear Antibody (ANA) Test Product Solution and Service
Table 25. Date of Enter into Antinuclear Antibody (ANA) Test Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 28. Global Antinuclear Antibody (ANA) Test Market Size Share by Type (2015-2020)
Table 29. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type (2021-2026)
Table 30. Global Antinuclear Antibody (ANA) Test Market Size Share by Application (2015-2020)
Table 31. Global Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 32. Global Antinuclear Antibody (ANA) Test Market Size Share by Application (2021-2026)
Table 33. North America Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 35. North America Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 36. North America Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 37. North America Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 38. North America Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 39. Europe Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 41. Europe Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 43. Europe Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 45. China Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 46. China Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 47. China Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 48. China Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 49. China Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 50. China Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 51. Japan Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 53. Japan Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 55. Japan Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 59. Southeast Asia Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 61. Southeast Asia Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 63. India Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 64. India Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 65. India Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 66. India Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 67. India Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 68. India Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Antinuclear Antibody (ANA) Test Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Antinuclear Antibody (ANA) Test Market Share (2019-2020)
Table 71. Central & South America Antinuclear Antibody (ANA) Test Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Antinuclear Antibody (ANA) Test Market Share by Type (2015-2020)
Table 73. Central & South America Antinuclear Antibody (ANA) Test Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Antinuclear Antibody (ANA) Test Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Bio-Rad Laboratories, Inc Company Details
Table 81. Bio-Rad Laboratories, Inc Business Overview
Table 82. Bio-Rad Laboratories, Inc Product
Table 83. Bio-Rad Laboratories, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 84. Bio-Rad Laboratories, Inc Recent Development
Table 85. ERBA Diagnostics, Inc Company Details
Table 86. ERBA Diagnostics, Inc Business Overview
Table 87. ERBA Diagnostics, Inc Product
Table 88. ERBA Diagnostics, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 89. ERBA Diagnostics, Inc Recent Development
Table 90. Trinity Biotech plc Company Details
Table 91. Trinity Biotech plc Business Overview
Table 92. Trinity Biotech plc Product
Table 93. Trinity Biotech plc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 94. Trinity Biotech plc Recent Development
Table 95. Thermo Fisher Scientific, Inc Company Details
Table 96. Thermo Fisher Scientific, Inc Business Overview
Table 97. Thermo Fisher Scientific, Inc Product
Table 98. Thermo Fisher Scientific, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 99. Thermo Fisher Scientific, Inc Recent Development
Table 100. Antibodies, Inc Company Details
Table 101. Antibodies, Inc Business Overview
Table 102. Antibodies, Inc Product
Table 103. Antibodies, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 104. Antibodies, Inc Recent Development
Table 105. EUROIMMUN AG Company Details
Table 106. EUROIMMUN AG Business Overview
Table 107. EUROIMMUN AG Product
Table 108. EUROIMMUN AG Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 109. EUROIMMUN AG Recent Development
Table 110. Immuno Concepts Business Overview
Table 111. Immuno Concepts Product
Table 112. Immuno Concepts Company Details
Table 113. Immuno Concepts Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 114. Immuno Concepts Recent Development
Table 115. Inova Diagnostics Company Details
Table 116. Inova Diagnostics Business Overview
Table 117. Inova Diagnostics Product
Table 118. Inova Diagnostics Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 119. Inova Diagnostics Recent Development
Table 120. Zeus Scientific Company Details
Table 121. Zeus Scientific Business Overview
Table 122. Zeus Scientific Product
Table 123. Zeus Scientific Revenue in Antinuclear Antibody (ANA) Test Business (2015-2020) (Million US$)
Table 124. Zeus Scientific Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antinuclear Antibody (ANA) Test Market Share by Type: 2020 VS 2026
Figure 2. Reagents & Assay Kits Features
Figure 3. Systems Features
Figure 4. Software & Service Features
Figure 5. Global Antinuclear Antibody (ANA) Test Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinical Laboratories Case Studies
Figure 8. Physician Office Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Antinuclear Antibody (ANA) Test Report Years Considered
Figure 11. Global Antinuclear Antibody (ANA) Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Antinuclear Antibody (ANA) Test Market Share by Regions: 2020 VS 2026
Figure 13. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antinuclear Antibody (ANA) Test Market Share by Players in 2019
Figure 16. Global Top Antinuclear Antibody (ANA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody (ANA) Test as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Antinuclear Antibody (ANA) Test Revenue in 2019
Figure 18. North America Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Antinuclear Antibody (ANA) Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 27. Bio-Rad Laboratories, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bio-Rad Laboratories, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 29. ERBA Diagnostics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. ERBA Diagnostics, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 31. Trinity Biotech plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Trinity Biotech plc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 33. Thermo Fisher Scientific, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Thermo Fisher Scientific, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 35. Antibodies, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Antibodies, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 37. EUROIMMUN AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. EUROIMMUN AG Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 39. Immuno Concepts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Immuno Concepts Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 41. Inova Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Inova Diagnostics Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 43. Zeus Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Zeus Scientific Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2020-2026
AbbottBio-Rad Laboratories, Inc
ERBA Diagnostics, Inc
Trinity Biotech plc
Thermo Fisher Scientific, Inc
Antibodies, Inc
EUROIMMUN AG
Immuno Concepts
Inova Diagnostics
Zeus Scientific